Study of the Reduction of the Prescriptions of Benzodiazepines and Related

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-01

Study Completion Date

2024-08-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The significant consumption of Benzodiazepines and related drugs in the elderly outside of good practice recommendations is a major issue in the care of the elderly. Adverse effects have been the subject of numerous studies, leading to falls, addictions and even deaths. The general practitioner is often faced with long-term medication intake which is not consistent with a good benefit/risk balance, but stopping or reducing the dosage remains a problem in current practice.

The Aftercare and Geriatric Rehabilitation services due to their operation (several weeks of hospitalization) seek to adapt the patient's therapies in order to obtain the most convincing benefit/risk balance possible. A reduction or withdrawal of treatments with Benzodiazepines or related drugs are therefore frequently initiated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Preventing Iatrogenic Dependence Linked to Hospitalisation in Elderly Patients Hospitalised in Acute Geriatrics

NCT06449053

An Acute Pathology

RECRUITING NA

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

NCT05307003

Delirium Delirium of Mixed Origin Delirium, Sepsis Associated +5 more

RECRUITING

Decreasing the Incidence of Delirium After Cardiac Surgery

NCT02119806

C.Surgical Procedure; Cardiac Delirium

WITHDRAWN PHASE4

Postoperative Cognitive Dysfunction in Geriatric Patients

NCT00512200

Delirium, Dementia, Amnestic, Cognitive Disorders Postoperative Complications Memory Disorders

COMPLETED

Predictive Value of β2-microspheres for Postoperative Delirium

NCT03130231

Postoperative Delirium

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this research is to quantify among the patients who benefited from a dosage reduction of Benzodiazepines and related drugs during a stay in the Geriatric Care and Aftercare and Rehabilitation department, the number of patients who had an increase of this treatment within 12 weeks following discharge from hospitalization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression in Old Age

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major subject (≥ 75 years old)
* Subject discharged from a geriatric Follow-up Care and Rehabilitation service for whom a reduction in the dosage of Benzodiazepines and related drugs was carried out during hospitalization and who returned home (individual or EHPAD) after hospitalization.
* Subject not opposing, after information, the reuse of their data for the purposes of this research.

Exclusion Criteria

* Subject having expressed opposition to participating in the study.
* Subject having treatment with Benzodiazepine to prevent recurrence of epileptic seizures.

Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No